Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon to Seek out Breast Cancer Biomarkers with MD Anderson

NEW YORK (GenomeWeb News) – Exiqon will seek microRNA biomarkers for breast cancer through a collaboration with the University of Texas MD Anderson Cancer Center, the company said today.
 
Under the collaboration, the Danish company Exiqon will use its miRCURY LNA locked nucleic acid nucleotide products to discover microRNA biomarkers for the Kleberg Center for Molecular Markers at the cancer center.
 
The collaboration is focused on identifying miRNA expression signatures associated with the relapse and progression of breast cancer, and Exiqon aims to develop and validate diagnostic tools that could be used to guide patient management.
 
Gordon Mills, who is director of the Kleberg Center, said the collaboration is part of the center’s efforts to unify DNA, RNA, and protein approaches in developing molecular markers that could help advance cancer treatment. 

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.